Abstract
Endothelins (ETs) are potent vasoconstrictive peptides released from the endothelium and other tissues, which act on target cells by receptorial calcium-mediated mechanisms. ET-1 levels are increased in diabetes, and observations suggest the involvement of ETs in the pathogenesis of diabetic angiopathy. However, it is not possible to exclude that ETs might also influence insulin secretion or function. In vivo infusion of ET-1 in rats induces hypoglycaemia and hyperinsulinemia and in vitro incubation with ET-1 stimulates insulin release by mouse islets. Therefore, ETs might be involved in a circulus vitiosus, resulting in hyperinsulinemia and diabetic angiopathy. The purpose of our study was to verify the effect of ET-1 on rat islets, in both the presence and absence of physiological glucose concentration. Moreover, we tested the effect of another isoform of endothelins, ET-3, and verified the involvement of extracellular calcium in such events. Islets were incubated with increasing ET-1 or ET-3, with or without glucose 5.6 mM. Other samples were prepared using calcium- free medium. Incubation in medium containing ET-1 and ET-3, in the presence of glucose and calcium, induced an increase in insulin release. When ET-1 and ET-3 were incubated without glucose and calcium, insulin release was not modified. Our studies demonstrate that: 1) ET-3, like ET-1, stimulates insulin release by rat isolated islets; 2) direct insulin stimulating effect on islets of both ET-1 and ET-3 is evident with physiological glucose concentrations and is calcium mediated. These results support the hypothesis of ET involvement in the regulation of insulin secretion.
Similar content being viewed by others
References
Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332: 411–415.
Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. USA 1989, 86: 2863–2867.
Masaki T. Endothelins: Homeostatic and compensatory actions in the circulatory and endocrine systems. Endocr. Rev. 1993, 3: 256–268.
Yanagisawa Y., Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol. Sci. 1989, 10: 374–378.
Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990, 348: 730–732.
Sakurai T., Yanagisawa M., Tokuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990, 348: 732–735.
Sakurai T., Kaji E.H., Winkel G.K., Ives H.E., Lodish H.F. Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. Proc. Natl. Acad. Sci. USA 1991, 88: 3185–3189.
Vigne P., Breittmayer J.P., Marsault R., Frelin C. Endothelin mobilizes Ca2+ from a caffeine- and ryanodine- insensitive intracellular pool in rat atrial cells. J. Biol. Chem. 1990, 265: 6782–6787.
Wagner-Mann C., Sturek M. Endothelin mediates Ca influx and release in porcine coronary smooth muscle cells. Am J. Physiol. 1991, 260: C771–C777.
Kasuya Y., Ishikawa T., Yanagisawa M., Kimura S., Goto K., Masaki T. Mechanism of contraction to endothelin in isolated porcine coronary artery. Am. J. Physiol. 1989, 257: H1828–H1835.
Hinson J.P., Vinson G.P., Kapas S., Teja R. The role of endothelin in the control of adrenocortical function: stimulation of endothelin release by ACTH and the effects of endothelin-1 and endothelin- 3 on steroidogenesis in rat and human adrenocortical cells. J. Endocrinol. 1991, 128: 275–280.
Hu Ren-Ming, Levin E.R., Pedram A., Frank H.J. Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 1993, 42: 351–358.
Oliver F.J., de la Rubia G., Feener E.P., Lee M.E., Loeken M.R., Shiba T., Quertermous T., King G.L. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J. Biol. Chem. 1991, 266: 23251–23256.
Harrison J.L.F., Ellis R.L., Ren-Ming H., Ali P. Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells. Endocrinology 1993, 133: 1093–1098.
Frank H.J.L., Levin E.R., Hu Ren-Mingtal Insulin stimulates endothelin binding and action on cultured smooth muscle cells. Endocrinology 1993, 3: 1092–1097.
Takahashi K., Ghatli M., Lam H.C., O’Halloran D.J., Bloom S.R. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990, 33: 306–310.
Fernandez-Cruz A., Patino R., Ibarra J., Molino A., Fernandez-Durango J., Moya J., Martell N. Increased plasma endothelin in diabetes: an atherosclerosis marker. J. Hypertens. 412: S117 (Abs). Diabetes Care 1994, 17: 574–577.
Bertello P.D., Veglio F., Pinna G., Gurioli L., Molino P., Alban S., Chiandussi L. Plasma endothelin in NIDDM patients with and without complications. Diabetes Care 1994, 17: 574–577.
Haak T., Jungmann E., Hillmann U., Felber A., Usadel H.K. Significance of increased endothelin level for development of sequelae of diabetes mellitus. Med. Klinmay 1993, 88: 291–296.
Zimmermann R.S., Maymind M. Endothelin-1 decreases glucose, inhibits glucagon, and stimulates insulin release in the rat. Metabolism 1995, 44: 1321–1325.
Gregersen S., Thomsen J.L., Brock B., Hermansen K. Endothelin-1 stimulates insulin secretion by direct action on islet of Langerhans in mice. Diabetologia 1996, 39: 1030–1035.
Lacy P.E., Kostianowsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967, 16: 35–39.
Purrello F., Vetri M., Gatta C., Gullo D. Vigneri R. Effects of high glucose on insulin secretion by isolated rat islets and purified β cells and possible role of glycosylation. Diabetes 1989, 38:1417–1422.
Herbert W., Lau S., Gottlieb C.W., Bleicher S.J. Coated charcoal immunoassay of insulin. J. Clin. Endocrinol. 1965, 26: 1375–1384.
Vane J.R., Anggard E.E., Botting R.M. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 1990, 323: 27–36.
Pinkney J.H., Stehouwer C.D., Coppack S.W., Yudkin J.S. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 1997, 46: S9–S13.
Piatti P.M., Monti L.D., Conti M., Baruffaldi L., Galli L., Phan C.V., Guazzini B., Pontiroli A.E., Pozza G. Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes 1996, 45: 316–321.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Carlo, E., Milanesi, A., Martini, C. et al. Endothelin-1 and endothelin-3 stimulate insulin release by isolated rat pancreatic islets. J Endocrinol Invest 23, 240–245 (2000). https://doi.org/10.1007/BF03343715
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343715